Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy

OBJECTIVE: To evaluate the occurrence of vitreous haemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR) and the efficacy of intravitreal bevacizumab (IVB) for VH in 5-year real-life data. METHODS AND ANALYSIS: 850 adult patients with type 1 (T1D) or type 2 diabetes (T2D) with PDR we...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirkkala, Joonas, Bloigu, Risto, Hautala, Nina Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936487/
https://www.ncbi.nlm.nih.gov/pubmed/31909195
http://dx.doi.org/10.1136/bmjophth-2019-000390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936487/
https://www.ncbi.nlm.nih.gov/pubmed/31909195
http://dx.doi.org/10.1136/bmjophth-2019-000390

Ejemplares similares